The Case CCC Minority Accrual Committee (MAC) would like to introduce a new name, Cultural Inclusion and Awareness Series for the Cultural Competency Series. The new name will allow the Committee to broaden the Series scope and post information which will have more research focus.
The MAC would like to initiate the retitled Series with the posting from the FDA Voice, 2/13/17, entitled “FDA Drug Trials Snapshots and Diversity When Testing New Drugs” by John J. Whyte, M.D., M.P.H., Director of Professional Affairs and Stakeholder Engagement at FDA’s Center for Drug Evaluation and Research.
Contains complete text, references and resources for all series entries
Think Cultural Health (PDF)